Promo !

ARA-290 10mg

Le prix initial était : $35.00.Le prix actuel est : $30.00.

ARA-290 (also known as cibinetide) is a synthetic 11-amino-acid peptide derived from erythropoietin (EPO). It is designed to reduce inflammation and promote nerve tissue repair by targeting the innate repair receptor, without stimulating red blood cell production. [1, 2]
Overview and Mechanism
  • Origin: Modeled from the helix-B surface of the EPO molecule.
  • Target: Activates the innate repair receptor (a complex of the EPO receptor and CD131).
  • Distinct Feature: Does not raise hemoglobin or red blood cell counts (non-erythropoietic).
  • Primary Focus: Studied for neuropathic pain and small fiber neuropathy (SFN).

ARA-290 10mg research-grade lyophilized peptide powder in a glass vial. Studied in innate repair receptor (IRR) signaling, neuroprotection, anti-inflammatory pathways and tissue-protective research models.

 

Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.

 

Purity
99%+ (Verified)
Form
Lyophilized peptide powder
Content
10 mg ARA-290 per vial
Packaging
Glass vial with sterile closure
Storage
Store lyophilized at 2–8 °C, desiccated and protected from light
Molecular Formula
C51H84N16O21
Molecular Weight
≈ 1257.3 g·mol⁻¹
Sequence (pyroglutamate)
Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-NH2
CAS Number
2381089-83-2

ARA-290 10mg

Research Overview

ARA-290 (Cibinetide) is an 11-amino-acid peptide engineered from erythropoietin (EPO) that selectively targets the innate repair receptor (IRR) rather than the classical erythropoietin receptor. In laboratory settings it is used to explore tissue-protective, neuroprotective and anti-inflammatory signaling pathways in diverse experimental models.

Primary Research Areas

  • Innate Repair Receptor (IRR) Signaling: Used in models probing IRR activation, downstream tissue-protective cascades and cell-survival pathways.
  • Neuroprotection & Neuropathy Models: Studied in experimental systems focused on small-fiber neuropathy, nerve injury, neuroinflammation and neural repair signaling.
  • Anti-inflammatory & Tissue-Protective Pathways: Frequently used to investigate cytokine modulation, inflammatory signaling and tissue-protection frameworks under metabolic or ischemic stress.
  • Cytoprotection & Cellular Stress Response: Included in research on cytoprotective mechanisms, organ-protection models and recovery of cells exposed to oxidative or metabolic challenge.
Reconstitution

Recommended solvent — Bacteriostatic water

Bacteriostatic water 10ml
ARA-290 (also known as cibinetide) 10mg is a synthetic, 11-amino-acid research peptide derived from erythropoietin (EPO) designed to target the innate repair receptor (IRR) without stimulating red blood cell production. It is strictly classified as a research compound and is not FDA-approved for any medical use. [1, 2, 3, 4]
Compound Profile & Status
  • Classification: Non-erythropoietic peptide analog
  • Regulatory Status: Not FDA-approved; restricted to laboratory and scientific research use only.
  • Proposed Mechanism: Selectively binds to the innate repair receptor (IRR) complex to study tissue protection and anti-inflammatory signaling in experimental models. [1, 2, 3, 4, 5]
Laboratory Handling & Storage
  • Vial Presentation: Typically supplied as a 10mg lyophilized (freeze-dried) powder in a sealed glass vial.
  • Reconstitution: Commonly mixed with a measured volume of bacteriostatic water (such as 1mL) for in vitro or preclinical workflows.
  • Storage: Lyophilized powder and reconstituted solutions require refrigeration (2–8 °C); reconstituted solutions are generally noted in handling literature for short-term stability (within 28 to 30 days). Freezing reconstituted peptides is avoided. [1, 2, 3, 4]
If you are looking for specific information, please let me know:
  • Are you looking for details on preclinical trial designs or mechanisms of action?
  • Do you need information regarding reconstitution math and handling guidelines?

What is Ara 290 used for?

ARA-290 10mg – "Official Website" – PROFORMA PEPTIDES UK

ARA 290 (also known as cibinetide) is an investigational synthetic peptide designed to reduce tissue inflammation and promote small nerve fiber repair. It has been studied primarily in clinical trials to treat severe neuropathic pain and nerve damage associated with conditions like sarcoidosis and type 2 diabetes.

National Institutes of Health (NIH) | (.gov) +2
Medical Research and Applications
  • Sarcoidosis-Associated Small Fiber Neuropathy: Studied to relieve burning pain, numbness, and sensory problems by helping regenerate damaged small nerve fibers.
    National Institutes of Health (NIH) | (.gov) +1
  • Diabetic Neuropathy: Evaluated for its ability to lower tissue inflammation and improve metabolic and nerve function in type 2 diabetes models and trials.
    National Institutes of Health (NIH) | (.gov) +1
  • Innate Repair Receptor (IRR) Activation:
     Engineered from erythropoietin (EPO) to trigger tissue-protective signaling without stimulating red blood cell production or raising blood viscosity.

Regulatory and Safety Status
  • Not Approved: ARA 290 is not approved by the FDA or regulatory agencies for routine human clinical use.
  • Development Status: Clinical development stalled after Phase II trials, and it remains an experimental compound restricted to laboratory and scientific research.
    Superpower +1

For diluting lyophilized peptide powders, use a sterile and suitable research solvent such as bacteriostatic water (BAC), which may help support handling stability and reduce contamination risk.

For convenient laboratory use, see Bacteriostatic water 10ml.

How long does it take Ara 290 to work?

ARA-290 (also known as cibinetide) begins working on an cellular level within hours, but noticeable clinical symptom relief typically takes 2 to 3 weeks of consistent dosing. Standard clinical research trials evaluate efficacy over a 28-day (4-week) treatment cycle, with tissue repair and pain reduction benefits sometimes persisting for weeks after the course finishes.

Timeline of Effects
  • Immediate (Hours): Acute cellular anti-inflammatory responses and reduction of inflammatory cytokine expression begin within 2 to 4 hours.
  • Short-Term (Weeks 2–3): Patients typically start to notice initial subjective relief from neuropathic pain and sensory discomfort.
  •  Standard research protocols use 4-week (28-day) cycles to achieve structural tissue benefits, such as measurable increases in small nerve fiber density.

    National Institutes of Health (NIH) | (.gov) +2
Important Context
  • ARA-290 is an investigational peptide and is not FDA-approved for therapeutic use.
  • Clinical data is primarily derived from controlled trials targeting neuropathic pain in conditions like sarcoidosis and type 2 diabetes.
  • Sourcing compounded peptides outside of a formal clinical setting carries risks regarding purity, sterility, and accurate dosing.
    Mind Body Neurology +3

Why Limitless Biochem?

Limitless BioChem is a trusted supplier of research compounds. Our products meet strict quality standards and are compliant with EU requirements. We focus on the safe and reliable supply of peptides and pure compounds intended exclusively for research or collector purposes.

This product is not intended for human or veterinary use. It is for collection or research purposes only. It cannot be used as food, dietary supplement or medicine! The information provided in the text on this page is for educational purposes only and does not constitute medical or other advice.

Avis

Il n’y a pas encore d’avis.

Soyez le premier à laisser votre avis sur “ARA-290 10mg”

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Panier

Save to list